GET THE PREMIUM SUBSCRIPTION FREE FOR 14 DAYS!

Ascendis Pharma A/S Stock Price (Quote) NASDAQ:ASND

$140.95 ( 2.14% ) Friday, 18th Jun 2021

Range Low Price High Price Comment
30 days $123.27 $142.00 Friday, 18th Jun 2021 ASND stock ended at $140.95. This is 2.14% more than the trading day before Thursday, 17th Jun 2021. During the day the stock fluctuated 4.65% from a day low at $135.18 to a day high of $141.46.
90 days $119.11 $148.62
52 weeks $119.11 $183.98

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
2021-06-18 $137.80 $141.46 $135.18 $140.95 524 468
2021-06-17 $132.80 $139.00 $131.69 $138.00 229 899
2021-06-16 $134.43 $136.81 $130.47 $133.68 206 358
2021-06-15 $133.02 $134.80 $131.51 $133.52 185 594
2021-06-14 $130.00 $138.79 $129.45 $134.40 296 676
2021-06-11 $127.36 $130.33 $125.96 $130.25 203 313
2021-06-10 $131.86 $132.02 $127.38 $128.22 203 358
2021-06-09 $131.30 $132.78 $129.82 $130.90 132 689
2021-06-08 $131.19 $131.64 $129.00 $130.83 125 719
2021-06-07 $129.70 $133.50 $128.36 $131.24 171 093
2021-06-04 $131.74 $131.98 $127.48 $130.36 90 624
2021-06-03 $126.72 $131.46 $124.05 $130.82 176 352
2021-06-02 $132.71 $134.80 $123.27 $128.94 517 544
2021-06-01 $135.33 $136.45 $127.34 $133.53 329 673
2021-05-28 $136.80 $140.92 $133.48 $134.38 247 936
2021-05-27 $134.28 $136.21 $133.00 $136.19 284 591
2021-05-26 $133.54 $136.37 $131.38 $133.77 213 316
2021-05-25 $134.85 $134.85 $131.56 $132.59 209 509
2021-05-24 $139.00 $139.00 $134.33 $135.09 146 682
2021-05-21 $138.59 $138.83 $135.14 $137.23 133 179
2021-05-20 $135.22 $142.00 $133.90 $137.47 171 869
2021-05-19 $137.43 $141.70 $132.54 $134.62 229 791
2021-05-18 $135.00 $141.30 $133.67 $138.12 258 900
2021-05-17 $131.92 $135.99 $130.02 $135.63 100 954
2021-05-14 $128.07 $132.95 $127.97 $132.18 177 159
2021-05-13 $136.64 $137.67 $126.86 $127.24 194 566
2021-05-12 $133.59 $137.29 $130.81 $136.96 161 481
2021-05-11 $127.44 $134.67 $126.58 $133.64 218 548
2021-05-10 $132.32 $132.32 $128.66 $130.07 121 005
2021-05-07 $134.68 $136.77 $131.28 $132.90 86 437
2021-05-06 $138.01 $139.49 $132.09 $132.90 189 481
2021-05-05 $139.99 $139.99 $134.49 $138.18 373 588
2021-05-04 $144.47 $144.47 $134.64 $138.39 579 827
2021-05-03 $144.93 $148.62 $142.15 $145.29 174 621
2021-04-30 $140.98 $147.85 $140.98 $144.97 355 317
2021-04-29 $138.82 $141.96 $135.38 $141.96 224 644
2021-04-28 $136.01 $138.53 $134.65 $138.27 102 948
2021-04-27 $136.11 $136.84 $134.01 $136.31 175 083
2021-04-26 $131.78 $136.84 $131.45 $135.65 186 953
2021-04-23 $133.16 $135.56 $130.01 $132.07 200 985
2021-04-22 $124.61 $134.00 $123.99 $131.85 394 409
2021-04-21 $124.74 $125.61 $122.65 $124.94 180 744
2021-04-20 $121.46 $125.57 $120.59 $125.03 137 005
2021-04-19 $121.46 $122.17 $119.11 $121.62 224 246
2021-04-16 $124.94 $126.43 $121.03 $121.95 307 219
2021-04-15 $125.38 $127.26 $123.82 $124.18 184 305
2021-04-14 $125.00 $128.00 $123.90 $124.24 141 919
2021-04-13 $123.83 $125.36 $121.35 $124.81 250 616
2021-04-12 $125.82 $126.13 $122.40 $123.37 460 597
2021-04-09 $129.22 $129.53 $124.18 $125.61 240 716

About Ascendis Pharma A/S

Ascendis Pharma A/S, a clinical stage biopharmaceutical company, develops various prodrug therapies to treat unmet medical needs. It is developing TransCon human growth hormone that has completed Phase II clinical trials in children and adults to treat growth hormone deficiency (GHD) and other indications; and TransCon Treprostinil that has completed Phase I clinical trial for the treatment of pulmonary arterial hypertension, a life-threatening d... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT